UniCredit boasts a CET1 ratio near 15%, liquidity coverage above 140%, and investment-grade ratings, supporting balance sheet ...

Brokerages see the acquisition as aligned with Coforge's stated ambition to shift more deeply into higher-value, AI-driven ...

Google is finally giving millions of people a way to escape the cringeworthy Gmail usernames they picked as teenagers without ...

Burry is the kind of outspoken outcast who makes for a good character in a Michael Lewis book: a neurologist by training who ...

U.S. President Donald Trump said on social media that the "powerful and deadly" strikes in the state of Sokoto were carried ...

After months of warning that the US could take military action to stop violence against Christians in Nigeria, President ...

Discover groundbreaking advancements in urologic oncology, including new standards for prostate, kidney, and bladder cancer ...

December 26, 2025 A newly released clinical review is drawing attention within medical and regulatory communities by consolidating available evidence on the side-effect profile of a widely prescribed ...

Immatics has innovative TCR therapies, strong cash position, and expanding clinical pipeline targeting solid tumors. Read for ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

The investment thesis for data analytics giant Palantir is under intense debate, highlighted by a stark divergence between high-profile investor exits and a ...

Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...